Marriott International Inc vs Tempus AI — how do they compare? Marriott International Inc trades at $365.88 (market cap $94.16B), while Tempus AI trades at $70.93 (market cap $12.58B). The key difference: Marriott International Inc is far larger — about 7.5× Tempus AI's market cap, and Marriott International Inc pays a 0.81% dividend while Tempus AI pays none. Which is the better fit depends on your goals — on Pluang, investors hold Marriott International Inc for 164 Days and Tempus AI for 23 Days on average.
| MAR | TEM | |
|---|---|---|
Market Cap | $94.16B | $12.58B |
Volume | 996,176 | 7,444,569 |
Sector | Consumer Cyclical | Broad Market / Factor |
52-Week High | $402.54 | $99.28 |
52-Week Low | $259.04 | $41.55 |
Typical Hold Time | 164 Days | 23 Days |
Enterprise Value | $111.47B | $13.21B |
Dividend Yield | 0.81% | — |
Signals from Pluang's Aura AI — not financial advice
Marriott International (MAR) trades at $361.08, up 1.28% with bullish technical signals and strong institutional support. The company shows steady revenue growth to $26.19B in 2025 with a 9.62% net margin, though valuation metrics appear elevated with a P/E of 37.38. Recent earnings beat expectations in Q1 and Q2 2026, while analysts maintain a consensus price target of $386.71 with 44% buy ratings.
MAR presents growth potential through travel recovery and strategic partnerships, but faces risks from high debt levels (58.83% debt-to-asset ratio) and economic sensitivity. The stock's technical strength and fundamental growth support a positive outlook, though investors should monitor debt management and macroeconomic impacts on travel demand.
Tempus AI (TEM) trades at $69.28, down 1.44% today, with a bullish technical signal despite bearish moving averages. The company shows strong revenue growth (2026: $1.4B) but remains unprofitable with negative margins. Recent FDA clearance for ECG-MR AI product and ESMO Congress presentations highlight innovation momentum. Analyst consensus is strongly bullish with 64% buy ratings and $72.60 price target.
TEM offers growth potential in AI-driven healthcare diagnostics but carries significant execution risk due to persistent losses. The stock's high P/S ratio (8.61) reflects growth expectations, yet negative ROE (-67.44%) and insider selling warrant caution. Upside depends on profitability improvements and commercial adoption of new AI products.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Marriott International Inc. of Maryland is a worldwide operator and franchisor of hotels. The Company franchises lodging facilities and vacation timesharing resorts under various brand names. Marriott also provides services to home and condominium owner associations for projects associated with several of its brands.
Read more on MAR →Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →